Three Big Questions for Stage 3 & Patient Engagement
Chilmark Research
JANUARY 17, 2014
For many, the delay of Stage 3 of the Meaningful Use program evoked a collective sigh of relief, providing a much-needed extra year to focus on the challenging requirements for patient engagement and interoperability. As one example, the report lauds GHC’s eHRA model, which is based on a shared EHR and shared clinical staff for data review.
Let's personalize your content